- Quantity
- 10 mg per vial
- Mol. weight
- 3367.9 g/mol
- Formula
- C152H252N44O42
- Current lot
- CJ-2609-29
CJC-1295 Without DAC, 10 mg Lyophilized Vial
- Quantity per vial10 mg
- FormLyophilized powder
- Purity≥99% by HPLC
- Molecular formulaC152H252N44O42
$74.99
10 mg lyophilized CJC-1295, GRF (1-29) analogue without the DAC linker. Purity “e99% by HPLC with a lot-specific certificate of analysis.
120 in stock
- Purity (HPLC)
- 99.7%
- Quantity
- 10 mg per vial
- Form
- Lyophilized powder in a sealed 3 mL glass vial
- Molecular formula
- C152H252N44O42
- Molecular weight
- 3367.9 g/mol
- Storage
- Lyophilized powder: store sealed at -20 °C, protected from light and moisture. Ships at ambient temperature with desiccant.
For laboratory research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, not for human consumption. Sold to qualified researchers and institutions for in-vitro research. Handle in accordance with your institution's safety guidelines.
CJ-2609-29- -20 °Cstore sealed, frozen
- Lightprotect from light
- Drydesiccant, keep dry
- 1Packed coldSealed vial, insulated mailer, desiccant
- 2Shipped trackedNext business day
- 3Straight to the freezerLog the lot against the certificate
Vial content and diluent volume → concentration, volume per draw and insulin-syringe units (U-100).
- Concentration
- —
- Volume per draw
- —
- Syringe units (U-100)
- —
- Draws per vial
- —
Laboratory preparation arithmetic (1 mL = 100 units on a U-100 syringe). No guidance on use. For laboratory research only; not for human or veterinary use.
Also known as: Modified GRF (1-29); CJC-1295 without DAC
Compare: vs AOD-9604 Lyophilized Powder, 5 mg Vial, ≥99% HPLC · vs BPC-157 Lyophilized Powder, 10 mg per Vial · vs BPC-157 Lyophilized Powder, 5 mg Vial · What HPLC, MS and CoA mean →
- Orders over $100−5%
SAVE5 - Orders over $200−10%
SAVE10
Each vial contains 10 mg of CJC-1295 as a lyophilized powder. The peptide is a synthetic 29-amino-acid GRF (1-29) analogue without the DAC linker. Purity is ≥99% by HPLC, with identity confirmed by mass spectrometry, so the purchaser can match the vial to a lot-specific certificate of analysis before the material enters an in-vitro protocol.
Specifications of the 10 mg CJC-1295 vial
- Compound
- CJC-1295, GRF (1-29) analogue, no DAC linker
- Quantity per vial
- 10 mg
- Form
- Lyophilized powder
- Purity
- ≥99% by HPLC
- Identity confirmation
- Mass spectrometry
- Molecular formula
- C152H252N44O42
- Molecular weight
- 3367.9 g/mol
- Documentation
- Lot-specific certificate of analysis, available for download
- Ships from
- Richmond, BC
- Packed weight
- 0.05 kg (courier weight, not net content)
- Package dimensions
- 8×8×6 cm
- Price
- $74.99 CAD
Why the no-DAC GRF (1-29) analogue is specified
Sequence class
The compound is a 29-amino-acid GRF (1-29) analogue. The DAC linker is not present, and the listing states this so the purchaser is not comparing two different materials.
Purity and method
Purity is ≥99% by HPLC. Identity is confirmed by mass spectrometry, and both figures appear on the certificate of analysis for the lot supplied.
Documented identity
Molecular formula is C152H252N44O42 and molecular weight is 3367.9 g/mol. These values can be checked against the analytical data for the lot.
Quantity per vial
The net content is 10 mg per vial. The item is sold as a single vial; no diluent or accessories are included.
Transit condition
The vial ships at ambient temperature with desiccant, in an insulated mailer from Richmond, BC.
Who the 10 mg CJC-1295 vial suits
The 10 mg vial fits a laboratory running an extended in-vitro series from one lot, where a single certificate of analysis covers the whole set of assays. It also suits a purchasing officer consolidating an order so that fewer lot numbers have to be recorded. A group that needs only a small quantity for a single method check may prefer a smaller vial size, since this item is supplied as 10 mg only. Sold for research use only, to laboratories and qualified researchers.
Store the lyophilized powder sealed at -20 °C, protected from light and moisture. The lot number on the vial matches the downloadable certificate of analysis stating identity, purity and test method. For laboratory research use only. Not for human or veterinary use.
Common questions
Does each vial come with a certificate of analysis?
Yes. Each lot ships with a downloadable lot-specific certificate of analysis stating purity ≥99% by HPLC, with identity confirmed by mass spectrometry.
How much CJC-1295 is in each vial?
Each vial contains 10 mg of lyophilized CJC-1295 without the DAC linker, a synthetic 29-amino-acid GRF (1-29) analogue, molecular weight 3367.9 g/mol.
How should the lyophilized powder be stored?
Store the sealed vial at -20 °C, protected from light and moisture. It ships from Richmond, BC at ambient temperature in an insulated mailer with desiccant, for research use only. For laboratory research use only. Not for human or veterinary use.
How it compares
CJC-1295 Without DAC, 10 mg Lyophilized Vial next to MOTS-c 10 mg Lyophilized Peptide Vial, ≥99% by HPLC (at the same price) and GHRP-2 Lyophilized Hexapeptide, 5 mg Vial (at the same price).
| CJC-1295 Without DAC, 10 mg Lyophilized Vial this page | MOTS-c 10 mg Lyophilized Peptide Vial, ≥99% by HPLC | GHRP-2 Lyophilized Hexapeptide, 5 mg Vial | |
|---|---|---|---|
| Price | $74.99 | $74.99 | $74.99 |
| Quantity | 10 mg per vial | 10 mg per vial | 5 mg per vial |
| Purity | 99.7% (HPLC) | 99.7% (HPLC) | 99.7% (HPLC) |
| Molecular weight | 3367.9 g/mol | 2174.6 g/mol | — |
| Formula | C152H252N44O42 | C101H152N28O22S2 | — |
| CAS | — | 1627580-64-6 | — |
| Form | Lyophilized powder in a sealed 3 mL glass vial | Lyophilized powder in a sealed 3 mL glass vial | Lyophilized powder in a sealed 3 mL glass vial |
Peer-reviewed literature
Journal articles indexed in PubMed for CJC-1295. Provided as bibliographic reference only; they do not describe this product or any use of it.
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsPMID 16352683DOI 10.1210/jc.2005-1536
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansPMID 41476424DOI 10.1177/03635465251357593
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsPMID 41490200DOI 10.5435/JAAOSGlobal-D-25-00236
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformancePMID 41966639DOI 10.1007/s40279-026-02437-0
Read before you buy
Last updated September 23, 2026
